Eligibility and Screening
Cross-source consensus on Eligibility and Screening from 1 sources and 4 claims.
1 sources · 4 claims
Preparation
Risks & contraindications
Other
Highlighted claims
- Psychological distress is assessed with K6 and suicidality with the Patient Safety Screener. — Responsible preoperative opioid use for hip or knee arthroplasty (OpioidHALT): a protocol for a randomised clinical trial of pharmacist-partnered opioid tapering prior to hip or knee arthroplasty
- Potentially eligible patients will be identified from surgery waitlists and contacted 4 to 6 months before surgery. — Responsible preoperative opioid use for hip or knee arthroplasty (OpioidHALT): a protocol for a randomised clinical trial of pharmacist-partnered opioid tapering prior to hip or knee arthroplasty
- Screening includes mental health assessment to identify people who may be at risk of psychological harm from tapering. — Responsible preoperative opioid use for hip or knee arthroplasty (OpioidHALT): a protocol for a randomised clinical trial of pharmacist-partnered opioid tapering prior to hip or knee arthroplasty
- Participants must be adults waitlisted for elective THA or TKA who use prescription opioids at least 4 days per week. — Responsible preoperative opioid use for hip or knee arthroplasty (OpioidHALT): a protocol for a randomised clinical trial of pharmacist-partnered opioid tapering prior to hip or knee arthroplasty